- Presentations
- 8
- Markets
- 1
Lamictal is a brand of Lamotrigine marketed by GlaxoSmithKline, with 8 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lamotrigine
- Brand owner
- GlaxoSmithKline
- Registered in
- United States
- Strengths and forms
- kit, 100 mg tablet, 150 mg tablet, 200 mg tablet, 25 mg tablet, 2 mg tablet for oral suspension, 25 mg tablet for oral suspension, 5 mg tablet for oral suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lamictal kit | GlaxoSmithKline | US FDA | Available on request |
| Lamictal 100 mg tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal 150 mg tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal 200 mg tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal 25 mg tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal 2 mg tablet for oral suspensionOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal 25 mg tablet for oral suspensionOral | GlaxoSmithKline | US FDA | Available on request |
| Lamictal 5 mg tablet for oral suspensionOral | GlaxoSmithKline | US FDA | Available on request |
Equivalent brands
Other brands of Lamotrigine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Lamictal
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.